Abstract
Psoriasis and atopic dermatitis (AD) are inflammatory diseases thought to be mediated by helper T-cell subtypes 1 and 2 (TH1 and TH2), respectively. Although psoriasis and AD show histopathologic differences during chronic disease, they are difficult to distinguish histologically during erythrodermic exacerbations. To determine whether the immune phenotype of helper T cells can differentiate erythrodermic psoriasis and erythrodermic AD by studying skin biopsy specimens of patients with psoriasis and AD during erythrodermic and chronic disease phases. We conducted a retrospective study using biopsy samples of psoriasis, AD, and erythroderma belonging to the surgical pathology files of the James Homer Wright Pathology Laboratories, Massachusetts General Hospital, and collected from January 1, 2004, through December 31, 2011. Samples were obtained from patients with chronic psoriasis (n = 20), chronic AD (n = 20), erythroderma subsequently diagnosed as psoriasis (n = 7), and erythroderma subsequently diagnosed as AD (n = 5). We evaluated immunohistochemical stains for CD3 and dual stains for CD4 and T-bet, GATA binding protein 3 (GATA3), signal transducer and activator of transcription 3 (STAT3), or basonuclin 2 (BNC2), which are ...Continue Reading
Citations
Nov 2, 2015·The Journal of Pediatrics·Mark A Strom, Jonathan I Silverberg
Jul 30, 2015·The Journal of Allergy and Clinical Immunology·Jonathan I Silverberg
Jan 21, 2016·Journal of Cutaneous Pathology·Andrea Primiani MoyRosalynn M Nazarian
Apr 16, 2016·Clinical and Experimental Dermatology·C WlodekC T Kennedy
Aug 3, 2016·International Journal of Molecular Sciences·Jung Eun KimHyun Jeong Park
Oct 22, 2016·The British Journal of Dermatology·K YamasakiUNKNOWN Japanese Brodalumab Study Group
Jan 27, 2017·International Journal of Molecular Sciences·Tae-Hoon ShinKyung-Sun Kang
Apr 11, 2017·Journal of Cutaneous Pathology·Andrea Primiani MoyRosalynn M Nazarian
Mar 24, 2018·The Journal of Dermatology·Shigetoshi SanoHidemi Nakagawa
Sep 14, 2017·Journal of Cutaneous Pathology·Gabriela RosaSteven D Billings
Aug 24, 2017·Journal of Cutaneous Pathology·Thinh ChauMaxwell A Fung
Sep 25, 2017·Clinical and Experimental Dermatology·A P MoyR M Nazarian
Dec 22, 2017·BMC Dermatology·Denis MiyashiroGil Benard
Sep 20, 2018·The Journal of Dermatology·Tomoyuki ShibataDaisuke Watanabe
Nov 16, 2018·Journal of Cutaneous Medicine and Surgery·Mark G KirchhofChih-Ho Hong
Sep 30, 2018·Journal of Applied Microbiology·M JinS-H Kim
Nov 14, 2018·The American Journal of Dermatopathology·Lauren Penn, Nooshin K Brinster
Nov 5, 2019·The Journal of Dermatological Treatment·Kelly A ReynoldsJashin J Wu
Jan 31, 2020·Dermatologic Therapy·Matteo MegnaClaudio Marasca
Dec 11, 2019·Molecular Diagnosis & Therapy·Yang LoTsen-Fang Tsai
Mar 18, 2020·Drugs·Shuai ShaoJohann E Gudjonsson
Oct 12, 2016·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Yukiko AonoNoriko Hamaura
Dec 21, 2017·Inflammation and Regeneration·Pawinee RerknimitrKenji Kabashima
Jun 30, 2018·Genes & Genomics·Li ZhangKuihua Xu
Jun 27, 2020·Current Opinion in Allergy and Clinical Immunology·Fatih A TopalMaja Hofmann
Jul 12, 2017·G3 : Genes - Genomes - Genetics·Cynthia KanagarathamDanuta Radzioch
Aug 26, 2019·Allergology International : Official Journal of the Japanese Society of Allergology·He LiWenru Su
Dec 11, 2020·Cytokine·Huixia WangYale Liu
Feb 12, 2021·Dermatologic Therapy·Emanuele TrovatoPietro Rubegni
Apr 16, 2021·Therapeutic Advances in Chronic Disease·Giampiero GirolomoniAna B Rossi
Feb 28, 2021·Clinical and Experimental Dermatology·S TsoA C Y Tso
Jun 18, 2021·Psoriasis : Targets and Therapy·Yang Lo, Tsen-Fang Tsai
Jul 16, 2021·Journal of the American Academy of Dermatology·Roberto MaglieEmiliano Antiga
Aug 26, 2021·Clinical and Translational Allergy·Maja A HofmannTorsten Zuberbier